SLOW-ACTING ANTI-ARTHROSIS MEDICATIONS FOR THE TREATMENT OF OSTEOARTHRITIS
https://doi.org/10.21518/2079-701X-2016-11-118-122
Abstract
The article tells about the epidemiological and pathogenetic aspects of osteoarthritis, current treatment approaches, primarily highlighting the slow-acting anti-arthrosis medications, chondroitin sulphate, glucosamine and their combinations. There are results of recent trials which studied the effect of the above mentioned medications on the symptoms and progression of osteoarthritis, as well as several pleiotropic effects of the combination of chondroitin sulfate and glucosamine.
About the Author
M. S. SVETLOVA
Petrozavodsk State University (PetrGU), Petrozavodsk
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
References
1. Балабанова Р.М., Эрдес Ш.Ф. Динамика распространенности ревматических заболеваний, входящих в XIII класс МКБ-10, в популяции взрослого населения Российской Федерации за 2000-2010 гг. Научно-практическая ревматология, 2012 3: 10-12.
2. Галушко Е.А., Эрдес Ш.Ф., Алексеева Л.И. Остеоартроз в амбулаторной практике. Современная ревматология, 2012, 4: 66-70.
3. Цурко В.В., Хитров Н.А. Остеоартроз: патогенез, клиника, лечение. Лечащий врач, 2000, 9: 23-28.
4. Насонов Е.Л. Современные направления терапии остеоартроза. Consilium Medicum, 2001, 9: 408-415.
5. Митрофанов В.А., Жаденов И.И., Пучиньян Д.М. Остеоартроз: факторы риска, патогенез и современная терапия. Саратовский научно-медицинский журнал, 2008, 2: 23-31.
6. Чичасова Н.В. Лечение боли у больных остеоартрозом различной локализации. Лечащий врач, 2014, 7: 44-50.
7. Zegels B., Crozes P., Reginster J.Y. Equivalense of single dose (1200 mg) compared to a threetime a day dose (400 mg) of chondroitin sulfate in patients with knee osteoarthritis. Results of a randomized double-blind placebo controlled study. Osteoarthritis and cartilage, 2012, 21: 22-27.
8. Martel-Pelletier J, Roubille C, Raynauld J-P. The long-term effects of SYSADOA treatment on knee osteoarthritis symptoms and progression of structural changes: participants from the osteoarthritis initiative progression cohort. Osteoarthritis and cartilage, 2013, 21: 63-312.
9. Martel-Pelletier J, Mineau F, Montell E et al. Effect of chondroitin sulfate on the factors involved in synovial inflammation. Osteoarthritis and cartilage, 2012, 54-296.
10. Wu W, Pasierb M. Physiological concentrations of glucosamine sulfate and glucosamine HCL can downregulate IL-1, kinins and MMPs in human osteoarthritic chondrocytes. Osteoarthritis and cartilage, 2012, 54-296.
11. Hochberg MC, Martel-Pelletier J, Monfort J et. al. Randomized, double-blind, multicenter, non inferiority clinical trial with combined glucosamine and chondroitin sulfate vs celecoxib for painful knee osteoarthritis. Osteoarthritis and cartilage, 2014, 20: 7-56.
12. Fransen М. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis, 2013, 20: 3954. Published Online First 6 January 2014.
13. Наумов А.В., Алексеева Л.И., Верткин А.Л. Ведение больных с остеоартритом и коморбидностью в общей врачебной практике. Клинические рекомендации консенсуса экспертов Российской Федерации. Москва, 2015.
14. Lambert C. Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research & Therapy, 2012, 14: R58.
15. Salta JA. Cancer Epidemiol. Biomarkers Prev, 2009, 18: 1419-1428.
16. Bell GA. Eur Epidemiol, 2012, 27: 593-603.
17. Navarro SL. PloS One, 2015, 26: 45-49.
18. Светлова М.С. Остеоартроз коленного сустава: диагностика и структурно-модифицирующая терапия Терафлексом. РМЖ, 2011, 19(19): 1959-1964.
Review
For citations:
SVETLOVA MS. SLOW-ACTING ANTI-ARTHROSIS MEDICATIONS FOR THE TREATMENT OF OSTEOARTHRITIS. Meditsinskiy sovet = Medical Council. 2016;(11):118-122. (In Russ.) https://doi.org/10.21518/2079-701X-2016-11-118-122
Views:
668
Email this article 